New hope for brain bleed patients: drug trial aims to prevent Stroke-Like damage
NCT ID NCT04362527
Summary
This study tested whether a drug called milrinone could help patients recover better after a severe brain bleed. The bleed can cause blood vessels in the brain to dangerously constrict, leading to stroke-like damage. In this large Phase 3 trial, 370 patients who developed this complication were randomly given either milrinone or a placebo to see if the drug improved their neurological recovery three months later.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASOSPASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHP Lariboisière
Paris, France
-
CHU Angers
Angers, France
-
CHU Besançon
Besançon, France
-
CHU Bordeaux
Bordeaux, France
-
CHU Brest
Brest, France
-
CHU Caen
Caen, France
-
CHU Dijon
Dijon, France
-
CHU Lille
Lille, France
-
CHU Nantes
Nantes, France
-
CHU Rennes
Rennes, France
-
CHU Tours
Tours, France
-
Hôpital Civils de Lyon
Lyon, France
-
Hôpital Fondation ROTHSCHILD
Paris, France
-
Hôpital Gabriel Montpied
Clermont-Ferrand, France
-
Hôpital Gui de Chauliac
Montpellier, France
-
Hôpital de Hautepierre
Strasbourg, 67098, France
Conditions
Explore the condition pages connected to this study.